AAAAAA
Results: 1-25/68
Authors:
Wood, TF
DiFronzo, LA
Rose, DM
Haigh, PL
Stern, SL
Wanek, L
Essner, R
Morton, DL
Citation: Tf. Wood et al., Does complete, resection of melanoma metastatic to solid intra-abdominal organs improve survival?, ANN SURG O, 8(8), 2001, pp. 658-662
Authors:
Habal, N
Gupta, RK
Bilchik, AJ
Yee, R
Leopoldo, Z
Ye, W
Elashoff, RM
Morton, DL
Citation: N. Habal et al., CancerVax, an allogeneic tumor cell vaccine, induces specific humoral and cellular immune responses in advanced colon cancer, ANN SURG O, 8(5), 2001, pp. 389-401
Authors:
Tsioulias, GJ
Gupta, RK
Tisman, G
Hsueh, EC
Essner, R
Wanek, LA
Morton, DL
Citation: Gj. Tsioulias et al., Serum TA90 antigen-antibody complex as a surrogate marker for the efficacyof a polyvalent allogeneic whole-cell vaccine (CancerVax) in melanoma, ANN SURG O, 8(3), 2001, pp. 198-203
Authors:
Wood, TF
Saha, S
Morton, DL
Tsioulias, GJ
Rangel, D
Hutchinson, W
Foshag, LJ
Bilchik, AJ
Citation: Tf. Wood et al., Validation of lymphatic mapping in colorectal cancer: In vivo, ex vivo, and laparoscopic techniques, ANN SURG O, 8(2), 2001, pp. 150-157
Authors:
Wood, TF
Spirt, M
Rangel, D
Shen, P
Tsioulias, GJ
Morton, DL
Bilchik, AJ
Citation: Tf. Wood et al., Lymphatic mapping improves staging during laparoscopic colectomy for cancer, SURG ENDOSC, 15(7), 2001, pp. 715-719
Authors:
Cochran, AJ
Morton, DL
Stern, S
Lana, AMA
Essner, R
Wen, DR
Citation: Aj. Cochran et al., Sentinel lymph nodes show profound downregulation of antigen-presenting cells of the paracortex: Implications for tumor biology and treatment, MOD PATHOL, 14(6), 2001, pp. 604-608
Authors:
Bilchik, AJ
Saha, S
Wiese, D
Stonecypher, JA
Wood, TF
Sostrin, S
Turner, RR
Wang, HJ
Morton, DL
Hoon, DSB
Citation: Aj. Bilchik et al., Molecular staging of early colon cancer on the basis of sentinel node analysis: A multicenter phase II trial, J CL ONCOL, 19(4), 2001, pp. 1128-1136
Authors:
Kelley, MC
Gupta, RK
Hsueh, EC
Yee, R
Stern, S
Morton, DL
Citation: Mc. Kelley et al., Tumor-associated antigen TA90 immune complex assay predicts recurrence andsurvival after surgical treatment of stage I-III melanoma, J CL ONCOL, 19(4), 2001, pp. 1176-1182
Authors:
Balch, CM
Buzaid, AC
Soong, SJ
Atkins, MB
Cascinelli, N
Coit, DG
Fleming, ID
Gershenwald, JE
Houghton, A
Kirkwood, JM
McMasters, KM
Mihm, MF
Morton, DL
Reintgen, DS
Ross, MI
Sober, A
Thompson, JA
Thompson, JF
Citation: Cm. Balch et al., Final version of the American Joint Committee on Cancer staging system forcutaneous melanoma, J CL ONCOL, 19(16), 2001, pp. 3635-3648
Authors:
Morton, DL
Citation: Dl. Morton, Cytoreductive surgery and adjuvant immunotherapy in the management of metastatic melanoma, TUMORI, 87(4), 2001, pp. S57-S59
Authors:
Habal, N
Giuliano, AE
Morton, DL
Citation: N. Habal et al., The use of sentinel lymphadenectomy to identify candidates for postoperative adjuvant therapy of melanoma and breast cancer, SEMIN ONCOL, 28(1), 2001, pp. 41-52
Authors:
Taback, B
Fujiwara, Y
Wang, HJ
Foshag, LJ
Morton, DL
Hoon, DSB
Citation: B. Taback et al., Prognostic significance of circulating microsatellite markers in the plasma of melanoma patients, CANCER RES, 61(15), 2001, pp. 5723-5726
Authors:
Haigh, PI
Lucci, A
Turner, RR
Bostick, PJ
Krasne, DL
Stern, SL
Morton, DL
Citation: Pi. Haigh et al., Carbon dye histologically confirms the identity of sentinel lymph nodes incutaneous melanoma, CANCER, 92(3), 2001, pp. 535-541
Authors:
DiFronzo, LA
Wanek, LA
Morton, DL
Citation: La. Difronzo et al., Earlier diagnosis sf second primary melanoma confirms the benefits of patient education and routine postoperative follow-up, CANCER, 91(8), 2001, pp. 1520-1524
Authors:
Ravindranath, MH
Gonzales, A
Soh, D
Nishimoto, K
Tam, WY
Bilchik, A
Morton, DL
O'Day, S
Citation: Mh. Ravindranath et al., Interleukin-2 binds to ganglioside GD(1b), BIOC BIOP R, 283(2), 2001, pp. 369-373
Authors:
Rose, DM
Essner, R
Hughes, TMD
Tang, PCY
Bilchik, A
Wanek, LA
Thompson, JF
Morton, DL
Citation: Dm. Rose et al., Surgical resection for metastatic melanoma to the liver - The John Wayne Cancer Institute and Sydney Melanoma Unit Experience, ARCH SURG, 136(8), 2001, pp. 950-955
Authors:
Broelsch, C
Brennan, MF
Niederhuber, JE
Wanebo, HJ
Morton, DL
Citation: C. Broelsch et al., Results of hepatic resection for sarcoma metastatic to liver - Discussion, ANN SURG, 234(4), 2001, pp. 547-548
Authors:
Nakayama, T
Taback, B
Turner, R
Morton, DL
Hoon, DSB
Citation: T. Nakayama et al., Molecular clonality of in-transit melanoma metastasis, AM J PATH, 158(4), 2001, pp. 1371-1378
Authors:
Shen, P
Conforti, AM
Essner, R
Cochran, AJ
Turner, RR
Morton, DL
Citation: P. Shen et al., Is the node of Cloquet the sentinel node for the iliac/obturator node group?, CANCER J, 6(2), 2000, pp. 93-97
Authors:
Balch, CM
Morton, DL
Citation: Cm. Balch et Dl. Morton, Second-time surgery for stage IV sarcoma (A model of sequential metastases), J AM COLL S, 191(2), 2000, pp. 193-195
Authors:
Chan, AD
Essner, R
Wanek, LA
Morton, DL
Citation: Ad. Chan et al., Judging the therapeutic value of lymph node dissections for melanaoma, J AM COLL S, 191(1), 2000, pp. 16-22
Authors:
Chan, AD
Essner, R
Wanek, LA
Morton, DL
Citation: Ad. Chan et al., Judging the therapeutic value of lymph node dissections for melanaoma - Reply, J AM COLL S, 191(1), 2000, pp. 23-23
Authors:
Shen, P
Wanek, LA
Morton, DL
Citation: P. Shen et al., Is adjuvant radiotherapy necessary after positive lymph node dissection inhead and neck melanomas?, ANN SURG O, 7(8), 2000, pp. 554-559
Authors:
Habal, N
Gupta, RK
Bilchik, AJ
Johnson, T
Morton, DL
Citation: N. Habal et al., TA90-IC, a new marker for advanced colon cancer, ANN SURG O, 7(5), 2000, pp. 352-356
Authors:
Hsueh, EC
Gupta, RK
Yee, R
Leopoldo, ZC
Qi, K
Morton, DL
Citation: Ec. Hsueh et al., Does endogenous immune response determine the outcome of surgical therapy for metastatic melanoma?, ANN SURG O, 7(3), 2000, pp. 232-238